All stock lists
Bio Essence Corp (OTC:BIOE)
US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
0.42+0.00 (+0.02%)
Insider Score
––Not scored
BIOE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
BIOE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 794.71 K | 500.54 K | 1.48 M | 136.80 K | 259.12 K | 22.19 K |
| Revenue Growth (YoY) | 206.69 % | 2155.79 % | 902.65 % | 1.57 % | 521.47 % | — |
| Cost of Revenue | 324.45 K | 181.18 K | 336.03 K | 41.04 K | 90.48 K | 1.60 K |
| Gross Profit | 470.26 K | 319.35 K | 1.14 M | 95.76 K | 168.64 K | 20.59 K |
| SG&A Expense | 190.97 K | 103.56 K | 113.79 K | 81.51 K | 107.42 K | 225.68 K |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 190.97 K | 103.56 K | 113.79 K | 81.51 K | 107.42 K | 225.68 K |
| Operating Income | 279.29 K | 215.79 K | 1.03 M | 14.25 K | 61.22 K | -205.09 K |
| Pretax Income | 280.49 K | 215.21 K | 1.03 M | 13.00 K | 60.66 K | -205.75 K |
| Tax Provision | 10.41 K | 9.84 K | 0.00 | 0.00 | 800.00 | 0.00 |
| Net Income | 270.08 K | 205.37 K | 1.03 M | 13.00 K | 59.86 K | -205.75 K |
| EPS (Basic) | 0.01 | 0.00 | 0.03 | 0.00 | 0.00 | -0.01 |
| EPS (Diluted) | 0.01 | 0.00 | 0.03 | 0.00 | 0.00 | -0.01 |
| Shares Outstanding | 50.89 M | 44.95 M | 38.01 M | 38.01 M | 38.01 M | 38.01 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.